Osteoarthritis Trial, Recruiting NCT07474896 Sponsor: Poznan University of Medical Sciences Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07474896
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 65 years of age or older
  • People who are scheduled for planned (non-emergency) shoulder surgery
  • People whose overall health status has been assessed by a doctor as fitting within a certain range of fitness for surgery (classified as ASA I, II, or III — confirm with trial site)
  • People for whom a nerve-blocking technique (regional anesthesia) is planned as part of their surgery
  • People who have signed a written consent form agreeing to take part

Who may not be able to join:

  • People who have a known allergy to local anaesthetic medicines
  • People for whom a continuous catheter nerve block technique is planned
  • People with a body mass index (a measure of weight relative to height) above 40
  • People who have a blood clotting disorder or who are taking blood-thinning medicines
  • People who already have a condition affecting the phrenic nerve (a nerve involved in breathing) before surgery
  • People who have an existing nerve or neurological condition affecting the arm or shoulder being operated on
  • People who are pregnant or breastfeeding
  • People who have taken part in another clinical trial within the past 30 days

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Malgorzata Reysner, MD PhD, Poznan University of Medical Sciences

Phone: +48618738313

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Poznan University of Medical Sciences
Registry
ClinicalTrials.gov
Start date
10 December 2025
Est. completion
1 January 2027

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Incidence of Hemidiaphragmatic Paresis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov